CIK 1537996
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2015-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 58.55% | 14 |
| Health Care Equipment & Supplies | 21.17% | 5 |
| Pharmaceuticals & Biotechnology | 8.78% | 5 |
| Health Care Providers & Services | 8.56% | 1 |
| Life Sciences Tools & Services | 2.94% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PATTERSON COMPANIES INC | Unclassified | 10.54% | |
| 2 | ENDOLOGIX INC | Unclassified | 9.88% | |
| 3 | MDT | Medtronic plc | Health Care | 9.32% |
| 4 | DGX | QUEST DIAGNOSTICS INC | Health Care | 8.56% |
| 5 | GREATBATCH INC | Unclassified | 7.86% | |
| 6 | BDX | BECTON DICKINSON & CO | Health Care | 7.26% |
| 7 | NXSTAGE MEDICAL INC | Unclassified | 6.27% | |
| 8 | MDRX | VERADIGM INC | Unclassified | 5.30% |
| 9 | IMPRIVATA INC | Unclassified | 5.04% | |
| 10 | ALKS | Alkermes plc. | Health Care | 4.26% |
12/26 names classified · sector 41.5% of weight · industry 41.5% · mkt cap 41.5%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 41.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 37% of book weight classified — the grid is NOT representative of the whole book.
Classified: 36.7% of book weight (9/14 names) · unclassified 63.3%: , MDRX, ATRC, CERS, HRTX. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PATTERSON COMPANIES INC | 1,225,000 | $53M | 10.5% | ADD 43% |
| 2 | ENDOLOGIX INC | 4,050,000 | $50M | 9.9% | HOLD |
| 3 | MDTMEDTRONIC PLC | 700,000 | $47M | 9.3% | ADD 40% |
| 4 | DGXQUEST DIAGNOSTICS INC | 700,000 | $43M | 8.6% | HOLD |
| 5 | GREATBATCH INC | 700,000 | $39M | 7.9% | TRIM −3% |
| 6 | BDXBECTON DICKINSON & CO | 275,000 | $36M | 7.3% | TRIM −31% |
| 7 | NXSTAGE MEDICAL INC | 2,000,000 | $32M | 6.3% | ADD 19% |
| 8 | MDRXVERADIGM INC | 2,150,000 | $27M | 5.3% | ADD 21% |
| 9 | IMPRIVATA INC | 1,425,000 | $25M | 5.0% | ADD 39% |
| 10 | ALKSALKERMES PLC | 365,000 | $21M | 4.3% | TRIM −9% |
| 11 | ATRCATRICURE INC | 825,000 | $18M | 3.6% | TRIM −7% |
| 12 | LUMINEX CORP | 950,000 | $16M | 3.2% | TRIM −5% |
| 13 | BIOBIO RAD LABS INC | 110,000 | $15M | 2.9% | TRIM −9% |
| 14 | CORIUM INTL INC | 1,325,000 | $12M | 2.5% | ADD 84% |
| 15 | RTI SURGICAL INC | 1,950,000 | $11M | 2.2% | TRIM −3% |
| 16 | Amarin Corp PLC | 5,700,000 | $11M | 2.2% | ADD 77% |
| 17 | AMGNAMGEN INC | 75,000 | $10M | 2.1% | NEW |
| 18 | SPECTRANETICS CORP | 785,000 | $9M | 1.8% | TRIM −25% |
| 19 | PRGOPERRIGO CO PLC | 50,000 | $8M | 1.6% | HOLD |
| 20 | OXFORD IMMUNOTEC GLOBAL PLC | 375,000 | $5M | 1.0% | TRIM −26% |
| 21 | CERSCERUS CORP | 900,000 | $4M | 0.8% | ADD 4% |
| 22 | LNTHLANTHEUS HLDGS INC | 615,000 | $3M | 0.5% | TRIM −65% |
| 23 | STREAMLINE HEALTH SOLUTIONS | 1,138,000 | $3M | 0.5% | HOLD |
| 24 | HRTXHERON THERAPEUTICS INC | 75,000 | $2M | 0.4% | NEW |
| 25 | NUVASIVE INC | 25,000 | $1M | 0.2% | NEW |
| 26 | GMEDGLOBUS MED INC | 45,000 | $930,000 | 0.2% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
